In this manuscript the authors demonstrate that circulating sclerostin levels are increased in type 2 diabetes mellitus and this correlation was independent of gender and age. Serum sclerostin also correlated with the duration of disease, glycated hemoglobin, bone turnover markers, and BMD.
http://www.ncbi.nlm.nih.gov/pubmed/22031520